T

Twentyeight-Seven Therapeutics

19 employees

Twentyeight-Seven Therapeutics is a developer of microRNAs designed to target regulatory proteins.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Developer Platform
Therapeutics
Life Science

Date founded

2016

Funding rounds raised

Total raised

$65M

from 11 investors over 11 rounds

T

Twentyeight-Seven Therapeutics raised $15M on May 9, 2019

Investors: Astellas Venture Capital L.L.C., Osage University Partners (OUP), MPM Capital, Longwood Fund, Sofinnova Partners and Vertex Ventures HC

T

Twentyeight-Seven Therapeutics raised $65M on September 6, 2018

Investors: Astellas Venture Capital L.L.C., Longwood Fund, MPM Capital and Vertex Ventures HC

T

Twentyeight-Seven Therapeutics raised undisclosed on April 5, 2016

Investors: MPM Capital

FAQ